Moreover, there are other studies that have found similar observation of higher CSF α-synuclein levels in Alzheimer’s patients compared to patients with primary α-synucleinopathies such as Parkinson’s disease, multiple system atrophy, and dementia with Lewy bodies [275,375,376,377]. Here, SNCA is linked to synucleinopathy.